USFDA bans import of drugs from Wockhardt’s Ankleshwar plant

By PTI
06 August, 2016

In yet another blow to drug maker Wockhardt, US Food and Drug Administration (USFDA) has banned import of products manufactured at its Ankleshwar plant for non compliance of manufacturing norms.

The company’s Ankleshwar plant manufactures bulk drugs, the USFDA said in a notice on its website. The import alert has been issued under ‘Import Alert 66-40’, which authorises the health regulator “detention without physical examination of drugs from firms which have not met drug GMPs”.

Already the company’s two plants at Chikalthana and Waluj have been banned from exporting drugs to the US by the US health regulator. In November 2013, the USFDA had imposed restrictions on import of medicines produced at the company’s Chikalthana plant at Aurangabad in Maharashtra.

Earlier in May, the USFDA had also issued an import alert on the company’s Waluj facility which makes injectables and solid dosages. Wockhardt shares ended at Rs.1,015.60 on BSE, up 0.49% from the previous close.

Like this report? Sign up for our daily newsletter to get our top reports.


Leave Your Comment
Wockhardt gets warning from USFDA over Chikalthana plant at Aurangabad

Wockhardt gets warning from USFDA over Chikalthana plant at Aurangabad

Lohit Jagwani 4 years ago
In another setback to Mumbai-based generic drugmaker Wockhardt Ltd, it has received an import alert from US Food and Drug Administration (FDA) for its Chikalthana...
USFDA issues warning letter to Cadila Pharmaceuticals

USFDA issues warning letter to Cadila Pharmaceuticals

PTI 3 years ago
The US Food and Drug Administration (USFDA) has issued a warning letter to Ahmedabad-based Cadila Pharmaceuticals for violating current good manufacturing practice norms at its...
Ranbaxy shares crash 30% after US FDA import alert

Ranbaxy shares crash 30% after US FDA import alert

TEAM VCC 4 years ago
Daiichi Sankyo controlled pharma major Ranbaxy Laboratories Ltd’s shares crashed over 30 per cent on Monday after US Food and Drug Administration (FDA) reportedly issued...
No Comments

USFDA bans import of drugs from Wockhardt’s Ankleshwar plant

Powered by WordPress.com VIP